. Author manuscript; available in PMC: 2023 Jun 1.

Published in final edited form as: Endocr Pract. 2022 Mar 14;28(6):610–614. doi: 10.1016/j.eprac.2022.03.006

TABLE 3:

Comparison of baseline characteristics of responders vs non-responders to SGLT2i

	RESPONDERS (N=9)	NON-RESPONDERS (N=3)	P
Age (years)	34.6±10.3	45.8±23.1	0.25
Weight (kg)	83.5±26.7^*	70.3±10.115.6	0.44
BMI (kg/m²)	29.4±7.7^*	24.6± 1.7	0.33
HbA1c(%) [mmol/mol]	9.3±2.4 [78.0±25.7]	8.0±0.5 [63.4±4.7]	0.37
Fasting plasma glucose (mg/dl)	175±98^*	144±43.7	0.62
Fasting C-peptide (ng/ml)	3.9 (2.6,6.1)^†	3.2 (1.8, 9.4)	0.95
24-hour urine glucose excretion (g/24 hrs.)	47.8±59.1^‡	16.2±5.6	0.41

N=8,

^†

N=7,

^‡

N=4